INNOAESTHETICS Hair Loss Control (4 × 2.5 ml)

INNOAESTHETICS Hair Loss Control (4 × 2.5 ml)

INNOAESTHETICS

Hair treatment / Therapy
    Topical / transdermal hair loss solution

    Description

    Hair Loss Control Man by INNOAESTHETICS is a transdermal hair treatment solution formulated to support hair growth and address male pattern hair loss (androgenetic alopecia) and other hair thinning conditions. Supplied as 4 vials of 2.5 ml each, this professional-use product combines multiple active ingredients — including Aminexil, Fenugreek extract, Biotin, Peptides, Saw Palmetto, Azelaic acid and zinc — aimed at improving scalp conditions, inhibiting DHT-related hair follicle weakening, boosting blood circulation, and promoting hair follicle vitality. The product is delivered via a TDS (transdermal delivery system) designed to facilitate penetration of actives through the skin barrier. Recommended for a minimum of 8 treatment sessions at 7-day intervals. (As per distributor description.)

    Bnefits

    • Combines multiple active ingredients (Aminexil, Biotin, Peptides, Fenugreek extract, Saw Palmetto, Azelaic acid) to act on different pathways involved in hair loss and thinning.
    • Targets androgenetic alopecia by inhibiting 5-alpha-reductase activity (via Saw Palmetto, zinc, Azelaic acid) and reducing scalp DHT impact on hair follicles.
    • Stimulates blood circulation in the scalp and nourishes hair follicles, potentially improving hair density and strength.
    • Formulated for transdermal delivery (TDS) to enhance absorption through the scalp skin barrier while being gentle and preservative-free.
    • Suitable for professional use in hair-loss treatment protocols, offering a structured treatment regimen (minimum 8 sessions at weekly intervals).
    • May support scalp health and mitigate dry scalp or poor circulation that contribute to hair thinning.

    Indications

    • Male androgenetic alopecia
    • Alopecia areata (per product claim)
    • Hair thinning, weak hair growth or early-stage hair loss
    • Scalp conditions associated with reduced circulation or follicle vitality
    • Supportive therapy to maintain hair density and prevent further hair loss

    Composition

    • Aminexil (a derivative of diaminopyrimidine oxide) — to reduce hair follicle miniaturization
    • Fenugreek extract — purported to stimulate scalp blood flow and support follicle nourishment
    • Biotin (Vitamin B7) — for hair structure support and strengthened hair roots
    • Peptides — for scalp nourishment and possible follicular stimulation
    • Saw Palmetto (Serenoa serrulata) — natural 5-alpha-reductase inhibitor to limit DHT formation
    • Azelaic acid — to inhibit 5-alpha-reductase and help scalp skin environment
    • Zinc — supports scalp health and may aid regulation of sebaceous secretion and enzyme activity

    Formulation

    • Sterile liquid solution for transdermal application or scalp injection (as per professional protocol).
    • Delivered in vials of 2.5 ml, 4 vials per box (total 10 ml).
    • pH approximately 6.5–7.5. Osmolarity: about 260–340 mOsm/kg (per product specifications).
    • Preservative-free, designed for TDS (transdermal delivery system).

    Packaging

    • Box containing 4 vials × 2.5 ml each (total 10 ml).
    • Each vial sealed under sterile conditions for professional use.
    • Labelled with batch number and usage instructions as per manufacturer’s data sheet.

    Usage

    • Intended for professional use only — must be administered by trained personnel.
    • Recommended minimum treatment schedule: 8 sessions, weekly (once every 7 days).
    • Apply solution to the scalp using appropriate method (topical application per TDS, or as per clinic protocol).
    • Follow scalp preparation protocol (cleanse scalp, possibly pre-treat with anaesthetic if injecting).
    • Monitor scalp skin condition, hair growth and patient response throughout treatment course.

    Contraindications

    • Known allergy or hypersensitivity to any of the active ingredients (Aminexil, Saw Palmetto, Biotin, Fenugreek, Azelaic acid, zinc).
    • Inflamed, infected or damaged scalp skin — avoid application or injection until skin condition has resolved.
    • Use in pregnant or breastfeeding men is not applicable; safety in women not established (as product is formulated for men).
    • Not recommended for individuals under legal adult age as per local regulations.
    • Not to be used concurrently with other unapproved hair-loss therapies without medical supervision.

    Adverse Effects

    • Possible scalp irritation, redness or sensitivity, especially with injection or if scalp skin is compromised.
    • Risk of allergic reaction or contact dermatitis in individuals sensitive to botanical extracts (Fenugreek, Saw Palmetto) or other components.
    • Uncertain efficacy; results may vary and not all users may respond (lack of robust clinical trial data publicly available).
    • Potential for infection if aseptic technique is not strictly followed during application or injection.

    Storage Conditions

    • Store vials in a cool, dry place away from direct sunlight.
    • Keep sealed until ready for use to maintain sterility and formulation stability.
    • Avoid freezing; protect from excessive heat and moisture.
    • Discard any unused portion after opening, if sterility cannot be guaranteed (as per clinical practice).

    Duration

    A standard treatment course comprises at least 8 weekly sessions (total duration 8 weeks). Maintenance frequency may be determined by clinician depending on response.

    Onset

    Initial scalp improvement (e.g. circulation, scalp comfort) may be perceived shortly after application; visible hair growth or reduction in hair loss generally expected after several weeks to months of consistent treatment, depending on individual response.

    Browse more Hair treatment / Therapy

    Top Treatments

    Top Cities in the UK